Autologous haematopoietic stem cell transplantation (HSCT) is the only treatment that is
able to induce long-term, drug-free and symptom-free remission in several refractory …

Mesenchymal stem cells (MSCs) have a potently immunosuppressive capacity in both
innate and adaptive immune responses. Consequently, MSCs transplantation has emerged …

Importance High-dose immunosuppressive therapy and autologous hematopoietic stem cell
transplantation (HSCT) have shown efficacy in systemic sclerosis in phase 1 and small …

Background Strong immunosuppression, including chemotherapy and immune-depleting
antibodies followed by autologous haemopoietic stem-cell transplantation (aHSCT), has …

Objective The aim of this study was to evaluate the safety of mesenchymal stem cell infusion
in patients with autoimmune diseases. Methods A total of 404 patients with autoimmune …

Importance Some patients with myasthenia gravis (MG) do not respond to conventional
treatment and have severe or life-threatening symptoms. Alternate and emerging therapies …

Reports from more than 600 hematopoietic stem cell transplants (HSCT) have appeared in
the medical literature for the last 1 and one-half decades. The patient's own stem cells are …

Systemic sclerosis is a progressive inflammatory disease that is frequently fatal and has
limited treatment options. High-dose chemotherapy with autologous hematopoietic cell …

Abstract Purpose of Review We summarise the current development of autologous
haematopoietic stem cell transplantation (AHSCT) in treating multiple sclerosis (MS) and …

Patients with hematologic malignancies and those undergoing hematopoietic cell
transplantation (HCT) face a complex set of challenges when considering options for fertility …